Concepts (335)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 60 | 2024 | 2148 | 4.570 |
Why?
|
| Cognition Disorders | 29 | 2015 | 1020 | 2.990 |
Why?
|
| Cognitive Dysfunction | 28 | 2023 | 1072 | 2.760 |
Why?
|
| Stroke | 17 | 2023 | 278 | 2.750 |
Why?
|
| Diet, Mediterranean | 8 | 2023 | 101 | 1.900 |
Why?
|
| Aged | 87 | 2024 | 9339 | 1.470 |
Why?
|
| Cognition | 30 | 2024 | 1371 | 1.400 |
Why?
|
| Humans | 123 | 2024 | 28462 | 1.350 |
Why?
|
| Female | 87 | 2024 | 15793 | 1.280 |
Why?
|
| Brain | 21 | 2024 | 1699 | 1.260 |
Why?
|
| Male | 84 | 2024 | 15367 | 1.220 |
Why?
|
| Dementia | 11 | 2023 | 580 | 1.160 |
Why?
|
| Aging | 15 | 2021 | 1572 | 1.140 |
Why?
|
| Aged, 80 and over | 51 | 2024 | 4904 | 1.100 |
Why?
|
| Biomarkers | 11 | 2023 | 601 | 1.090 |
Why?
|
| Chicago | 22 | 2021 | 941 | 1.010 |
Why?
|
| Stress, Psychological | 4 | 2016 | 243 | 0.930 |
Why?
|
| Depression | 4 | 2022 | 454 | 0.850 |
Why?
|
| Neuropsychological Tests | 22 | 2021 | 1254 | 0.840 |
Why?
|
| Ischemic Attack, Transient | 1 | 2023 | 18 | 0.830 |
Why?
|
| Diet, Western | 1 | 2022 | 12 | 0.800 |
Why?
|
| Attitude | 1 | 2022 | 36 | 0.790 |
Why?
|
| Amyloid beta-Peptides | 8 | 2024 | 328 | 0.780 |
Why?
|
| Longitudinal Studies | 30 | 2021 | 1391 | 0.780 |
Why?
|
| Cardiology | 1 | 2022 | 56 | 0.750 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2022 | 1196 | 0.730 |
Why?
|
| Risk Factors | 32 | 2023 | 2421 | 0.710 |
Why?
|
| Community Participation | 1 | 2020 | 18 | 0.710 |
Why?
|
| Disease Progression | 13 | 2023 | 719 | 0.670 |
Why?
|
| Prospective Studies | 12 | 2023 | 1810 | 0.660 |
Why?
|
| Apolipoproteins E | 12 | 2023 | 254 | 0.660 |
Why?
|
| Hypertension | 6 | 2022 | 226 | 0.630 |
Why?
|
| Brain Concussion | 3 | 2023 | 15 | 0.600 |
Why?
|
| tau Proteins | 6 | 2023 | 239 | 0.600 |
Why?
|
| Cohort Studies | 21 | 2024 | 1948 | 0.590 |
Why?
|
| Football | 3 | 2023 | 37 | 0.590 |
Why?
|
| Apolipoprotein E4 | 11 | 2021 | 267 | 0.560 |
Why?
|
| Cerebrovascular Disorders | 4 | 2015 | 134 | 0.560 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2013 | 28 | 0.560 |
Why?
|
| Sex Characteristics | 4 | 2023 | 120 | 0.550 |
Why?
|
| Incidence | 16 | 2023 | 779 | 0.550 |
Why?
|
| Independent Living | 5 | 2023 | 320 | 0.540 |
Why?
|
| Cardiovascular Diseases | 5 | 2019 | 373 | 0.470 |
Why?
|
| Cerebral Infarction | 2 | 2013 | 150 | 0.450 |
Why?
|
| Cross-Sectional Studies | 12 | 2022 | 939 | 0.440 |
Why?
|
| Middle Aged | 21 | 2023 | 9306 | 0.420 |
Why?
|
| Brain Infarction | 3 | 2023 | 75 | 0.400 |
Why?
|
| Sex Factors | 8 | 2023 | 480 | 0.400 |
Why?
|
| Dietary Approaches To Stop Hypertension | 3 | 2021 | 37 | 0.390 |
Why?
|
| Dietary Supplements | 5 | 2022 | 67 | 0.390 |
Why?
|
| Leukoencephalopathies | 1 | 2011 | 12 | 0.370 |
Why?
|
| Diet Surveys | 3 | 2022 | 26 | 0.370 |
Why?
|
| Vitamin B 12 | 2 | 2011 | 13 | 0.360 |
Why?
|
| Ambulatory Care Facilities | 3 | 2022 | 40 | 0.360 |
Why?
|
| Dementia, Vascular | 3 | 2007 | 45 | 0.360 |
Why?
|
| Neuroimaging | 4 | 2021 | 133 | 0.340 |
Why?
|
| Smoking | 3 | 2012 | 179 | 0.340 |
Why?
|
| Positron-Emission Tomography | 3 | 2023 | 90 | 0.340 |
Why?
|
| Neurodegenerative Diseases | 3 | 2023 | 124 | 0.330 |
Why?
|
| Healthy Lifestyle | 4 | 2024 | 46 | 0.330 |
Why?
|
| White Matter | 3 | 2022 | 142 | 0.320 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2021 | 382 | 0.310 |
Why?
|
| Risk Assessment | 10 | 2022 | 676 | 0.300 |
Why?
|
| Comorbidity | 8 | 2021 | 502 | 0.300 |
Why?
|
| Genome-Wide Association Study | 4 | 2020 | 291 | 0.290 |
Why?
|
| Atrial Fibrillation | 2 | 2022 | 134 | 0.290 |
Why?
|
| Memory Disorders | 4 | 2019 | 171 | 0.290 |
Why?
|
| Cerebral Arteries | 2 | 2007 | 25 | 0.290 |
Why?
|
| Women's Health | 2 | 2019 | 177 | 0.280 |
Why?
|
| Follow-Up Studies | 12 | 2021 | 1868 | 0.280 |
Why?
|
| Population Surveillance | 2 | 2021 | 110 | 0.280 |
Why?
|
| Time Factors | 6 | 2021 | 1497 | 0.280 |
Why?
|
| Vitamin B 6 | 1 | 2006 | 4 | 0.270 |
Why?
|
| Folic Acid | 1 | 2006 | 21 | 0.270 |
Why?
|
| Parkinsonian Disorders | 3 | 2022 | 227 | 0.260 |
Why?
|
| Surveys and Questionnaires | 6 | 2022 | 1216 | 0.260 |
Why?
|
| Urban Health | 1 | 2006 | 23 | 0.260 |
Why?
|
| Patient Selection | 2 | 2021 | 209 | 0.260 |
Why?
|
| Movement Disorders | 1 | 2006 | 91 | 0.250 |
Why?
|
| Diet | 5 | 2022 | 221 | 0.250 |
Why?
|
| Vitamin D | 2 | 2022 | 41 | 0.240 |
Why?
|
| Parkinson Disease | 4 | 2022 | 847 | 0.240 |
Why?
|
| Proportional Hazards Models | 6 | 2015 | 352 | 0.240 |
Why?
|
| Overweight | 2 | 2022 | 77 | 0.230 |
Why?
|
| United States | 10 | 2022 | 2185 | 0.220 |
Why?
|
| Early Diagnosis | 2 | 2020 | 68 | 0.220 |
Why?
|
| Exercise | 4 | 2022 | 476 | 0.210 |
Why?
|
| Risk | 5 | 2015 | 208 | 0.210 |
Why?
|
| Day Care, Medical | 3 | 2008 | 7 | 0.210 |
Why?
|
| Emergency Medical Services | 2 | 2020 | 29 | 0.210 |
Why?
|
| Life Style | 5 | 2023 | 198 | 0.200 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2022 | 186 | 0.200 |
Why?
|
| Gender Identity | 2 | 2023 | 23 | 0.200 |
Why?
|
| Causality | 4 | 2011 | 56 | 0.200 |
Why?
|
| Food | 1 | 2022 | 35 | 0.200 |
Why?
|
| Genetic Loci | 3 | 2020 | 54 | 0.200 |
Why?
|
| Genetic Testing | 1 | 2022 | 58 | 0.200 |
Why?
|
| Crime Victims | 1 | 2022 | 32 | 0.200 |
Why?
|
| Health Status Disparities | 2 | 2019 | 75 | 0.190 |
Why?
|
| Lutein | 1 | 2021 | 5 | 0.190 |
Why?
|
| Zeaxanthins | 1 | 2021 | 5 | 0.190 |
Why?
|
| Carotenoids | 1 | 2021 | 18 | 0.190 |
Why?
|
| Healthcare Disparities | 2 | 2019 | 87 | 0.190 |
Why?
|
| Logistic Models | 6 | 2011 | 397 | 0.180 |
Why?
|
| Age Factors | 8 | 2019 | 793 | 0.180 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2020 | 13 | 0.180 |
Why?
|
| Clergy | 3 | 2006 | 93 | 0.180 |
Why?
|
| Prevalence | 5 | 2021 | 473 | 0.180 |
Why?
|
| Neurofilament Proteins | 1 | 2020 | 17 | 0.180 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 42 | 0.180 |
Why?
|
| Vertigo | 1 | 2000 | 8 | 0.170 |
Why?
|
| Program Development | 1 | 2020 | 64 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2021 | 174 | 0.170 |
Why?
|
| Endothelium | 1 | 2020 | 12 | 0.170 |
Why?
|
| Advance Care Planning | 1 | 2020 | 12 | 0.170 |
Why?
|
| Terminal Care | 1 | 2020 | 27 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 285 | 0.170 |
Why?
|
| Vascular Diseases | 1 | 2020 | 44 | 0.170 |
Why?
|
| Disability Evaluation | 2 | 2007 | 293 | 0.160 |
Why?
|
| Age Distribution | 3 | 2011 | 90 | 0.160 |
Why?
|
| Heart Failure, Diastolic | 1 | 2018 | 2 | 0.160 |
Why?
|
| Interviews as Topic | 2 | 2015 | 136 | 0.160 |
Why?
|
| Women's Health Services | 1 | 2018 | 9 | 0.150 |
Why?
|
| Patient Care Management | 1 | 2018 | 19 | 0.150 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2018 | 16 | 0.150 |
Why?
|
| Cardiovascular Agents | 1 | 2018 | 27 | 0.150 |
Why?
|
| American Heart Association | 1 | 2018 | 18 | 0.150 |
Why?
|
| Culturally Competent Care | 1 | 2018 | 11 | 0.150 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2018 | 25 | 0.150 |
Why?
|
| Emigrants and Immigrants | 1 | 2018 | 24 | 0.150 |
Why?
|
| Genotype | 3 | 2016 | 352 | 0.150 |
Why?
|
| Mortality | 2 | 2016 | 88 | 0.150 |
Why?
|
| Linear Models | 3 | 2015 | 255 | 0.150 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2018 | 42 | 0.140 |
Why?
|
| Emergency Medical Service Communication Systems | 1 | 2017 | 1 | 0.140 |
Why?
|
| Amyloid | 3 | 2022 | 58 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2018 | 56 | 0.140 |
Why?
|
| Public Health | 1 | 2018 | 68 | 0.140 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 59 | 0.140 |
Why?
|
| Self Report | 2 | 2022 | 226 | 0.140 |
Why?
|
| Education | 3 | 2006 | 46 | 0.140 |
Why?
|
| Sex Distribution | 2 | 2011 | 81 | 0.140 |
Why?
|
| Cognitive Aging | 1 | 2018 | 79 | 0.140 |
Why?
|
| Homes for the Aged | 2 | 2007 | 10 | 0.140 |
Why?
|
| Nursing Homes | 2 | 2007 | 37 | 0.130 |
Why?
|
| Lipoprotein(a) | 1 | 2016 | 5 | 0.130 |
Why?
|
| Communication | 1 | 2017 | 124 | 0.130 |
Why?
|
| Health Promotion | 1 | 2018 | 162 | 0.130 |
Why?
|
| Adult | 9 | 2023 | 8152 | 0.130 |
Why?
|
| Survival Analysis | 2 | 2015 | 267 | 0.130 |
Why?
|
| Dyslipidemias | 1 | 2016 | 18 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 35 | 0.120 |
Why?
|
| Psychological Tests | 1 | 2015 | 53 | 0.120 |
Why?
|
| Models, Genetic | 1 | 2015 | 35 | 0.120 |
Why?
|
| Residence Characteristics | 3 | 2011 | 216 | 0.120 |
Why?
|
| Interpersonal Relations | 2 | 2015 | 104 | 0.120 |
Why?
|
| Tissue Donors | 2 | 2012 | 79 | 0.110 |
Why?
|
| Bias | 2 | 2012 | 40 | 0.110 |
Why?
|
| Heart Failure | 3 | 2022 | 175 | 0.110 |
Why?
|
| Prognosis | 4 | 2019 | 824 | 0.110 |
Why?
|
| Patient Compliance | 1 | 2015 | 165 | 0.110 |
Why?
|
| Antioxidants | 2 | 2005 | 65 | 0.110 |
Why?
|
| Odds Ratio | 2 | 2011 | 274 | 0.100 |
Why?
|
| Memory | 3 | 2006 | 308 | 0.100 |
Why?
|
| Intermediate Filaments | 2 | 2023 | 20 | 0.100 |
Why?
|
| Alleles | 4 | 2021 | 213 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2015 | 329 | 0.100 |
Why?
|
| Patient Dropouts | 1 | 2012 | 28 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 494 | 0.100 |
Why?
|
| Community Health Services | 2 | 2009 | 36 | 0.090 |
Why?
|
| Social Support | 1 | 2012 | 216 | 0.090 |
Why?
|
| Blood Pressure | 2 | 2022 | 204 | 0.090 |
Why?
|
| Psychometrics | 2 | 2010 | 242 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2021 | 3612 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 2 | 2010 | 83 | 0.090 |
Why?
|
| Neocortex | 1 | 2010 | 32 | 0.090 |
Why?
|
| Confidence Intervals | 3 | 2005 | 97 | 0.090 |
Why?
|
| Decision Support Techniques | 2 | 2010 | 52 | 0.090 |
Why?
|
| Qualitative Research | 2 | 2023 | 124 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2009 | 992 | 0.090 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 137 | 0.080 |
Why?
|
| Lewy Body Disease | 1 | 2010 | 99 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 3 | 0.080 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2009 | 3 | 0.080 |
Why?
|
| Interferon Regulatory Factors | 1 | 2009 | 2 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2009 | 53 | 0.080 |
Why?
|
| Brain Mapping | 1 | 2010 | 168 | 0.080 |
Why?
|
| Coronary Artery Disease | 2 | 2022 | 140 | 0.080 |
Why?
|
| Geriatric Assessment | 3 | 2021 | 214 | 0.070 |
Why?
|
| Community Health Nursing | 1 | 2008 | 9 | 0.070 |
Why?
|
| Multiple Sclerosis | 1 | 2009 | 102 | 0.070 |
Why?
|
| Home Care Services | 1 | 2008 | 22 | 0.070 |
Why?
|
| Vitamin E | 2 | 2005 | 45 | 0.070 |
Why?
|
| Isometric Contraction | 1 | 2007 | 13 | 0.070 |
Why?
|
| Lower Extremity | 1 | 2007 | 40 | 0.070 |
Why?
|
| Life Expectancy | 2 | 2022 | 28 | 0.070 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2007 | 15 | 0.070 |
Why?
|
| Muscle Strength | 1 | 2007 | 138 | 0.070 |
Why?
|
| Quality of Life | 2 | 2022 | 660 | 0.070 |
Why?
|
| Postural Balance | 1 | 2007 | 122 | 0.060 |
Why?
|
| Patient Admission | 1 | 2005 | 26 | 0.060 |
Why?
|
| Research Design | 2 | 2021 | 208 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 371 | 0.060 |
Why?
|
| Hallucinations | 1 | 2005 | 64 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2007 | 181 | 0.060 |
Why?
|
| Tocopherols | 1 | 2005 | 9 | 0.060 |
Why?
|
| Socioeconomic Factors | 3 | 2010 | 311 | 0.060 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2023 | 12 | 0.050 |
Why?
|
| Caloric Restriction | 1 | 2023 | 16 | 0.050 |
Why?
|
| Seafood | 1 | 2003 | 14 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 191 | 0.050 |
Why?
|
| Gait | 1 | 2007 | 411 | 0.050 |
Why?
|
| Urban Population | 2 | 2003 | 159 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2003 | 39 | 0.050 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 8 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 334 | 0.050 |
Why?
|
| Vitamins | 1 | 2022 | 21 | 0.050 |
Why?
|
| Fraud | 1 | 2022 | 20 | 0.050 |
Why?
|
| Motivation | 1 | 2023 | 99 | 0.050 |
Why?
|
| Polypharmacy | 1 | 2022 | 7 | 0.050 |
Why?
|
| Vitamin K | 1 | 2022 | 7 | 0.050 |
Why?
|
| Anthocyanins | 1 | 2022 | 11 | 0.050 |
Why?
|
| Fruit | 1 | 2022 | 26 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2022 | 54 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2022 | 34 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 35 | 0.050 |
Why?
|
| Frailty | 1 | 2022 | 35 | 0.050 |
Why?
|
| Vegetables | 1 | 2021 | 24 | 0.050 |
Why?
|
| Survivors | 1 | 2022 | 72 | 0.050 |
Why?
|
| Atrial Appendage | 1 | 2022 | 37 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 133 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2022 | 81 | 0.050 |
Why?
|
| Probability | 1 | 2021 | 91 | 0.050 |
Why?
|
| Accelerometry | 1 | 2021 | 88 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2022 | 64 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2022 | 90 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2020 | 8 | 0.050 |
Why?
|
| Activities of Daily Living | 2 | 2007 | 612 | 0.050 |
Why?
|
| Athletes | 1 | 2021 | 89 | 0.050 |
Why?
|
| Weight Loss | 1 | 2022 | 128 | 0.050 |
Why?
|
| Neurofibrillary Tangles | 1 | 2022 | 196 | 0.050 |
Why?
|
| Executive Function | 1 | 2021 | 115 | 0.050 |
Why?
|
| Catheter Ablation | 1 | 2022 | 72 | 0.050 |
Why?
|
| Tremor | 1 | 2022 | 117 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2020 | 30 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2015 | 600 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2020 | 30 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2022 | 113 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2020 | 66 | 0.040 |
Why?
|
| Illinois | 1 | 2021 | 247 | 0.040 |
Why?
|
| Coronary Circulation | 1 | 2020 | 26 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2021 | 146 | 0.040 |
Why?
|
| Educational Status | 3 | 2007 | 298 | 0.040 |
Why?
|
| Autopsy | 1 | 2021 | 346 | 0.040 |
Why?
|
| Cardiovascular System | 1 | 2019 | 15 | 0.040 |
Why?
|
| Nutrition Assessment | 3 | 2005 | 45 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 164 | 0.040 |
Why?
|
| Survival Rate | 2 | 2011 | 356 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 3619 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 233 | 0.040 |
Why?
|
| Epidemiologic Studies | 2 | 2012 | 25 | 0.040 |
Why?
|
| Animals | 2 | 2018 | 3798 | 0.040 |
Why?
|
| Asia, Western | 1 | 2018 | 2 | 0.040 |
Why?
|
| Indian Ocean Islands | 1 | 2018 | 2 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 295 | 0.040 |
Why?
|
| Hospitalization | 1 | 2021 | 322 | 0.040 |
Why?
|
| Hippocampus | 1 | 2020 | 281 | 0.040 |
Why?
|
| Cultural Characteristics | 1 | 2018 | 21 | 0.040 |
Why?
|
| Focus Groups | 1 | 2018 | 93 | 0.040 |
Why?
|
| Ambulances | 1 | 2017 | 1 | 0.040 |
Why?
|
| Caregivers | 1 | 2020 | 203 | 0.040 |
Why?
|
| Pregnancy | 1 | 2018 | 340 | 0.040 |
Why?
|
| Models, Statistical | 2 | 2012 | 128 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2020 | 192 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 196 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 11 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2007 | 113 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 228 | 0.030 |
Why?
|
| Registries | 1 | 2018 | 191 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 44 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2018 | 170 | 0.030 |
Why?
|
| Mental Status Schedule | 2 | 2007 | 98 | 0.030 |
Why?
|
| Neurologic Examination | 2 | 2007 | 115 | 0.030 |
Why?
|
| Georgia | 1 | 2016 | 11 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 32 | 0.030 |
Why?
|
| Diagnosis | 1 | 2015 | 24 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 308 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 7 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 42 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 177 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 2100 | 0.030 |
Why?
|
| Lewy Bodies | 1 | 2015 | 193 | 0.030 |
Why?
|
| Medicare | 1 | 2014 | 121 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2014 | 358 | 0.030 |
Why?
|
| Markov Chains | 1 | 2012 | 32 | 0.020 |
Why?
|
| Fumarates | 1 | 2011 | 2 | 0.020 |
Why?
|
| Maleates | 1 | 2011 | 2 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 628 | 0.020 |
Why?
|
| Phenanthrolines | 1 | 2010 | 4 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 2010 | 6 | 0.020 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2010 | 6 | 0.020 |
Why?
|
| Thiazoles | 1 | 2010 | 19 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 2010 | 36 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 58 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 58 | 0.020 |
Why?
|
| Nursing Administration Research | 1 | 2008 | 3 | 0.020 |
Why?
|
| Nursing Assessment | 1 | 2008 | 37 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2008 | 42 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2008 | 66 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2007 | 29 | 0.020 |
Why?
|
| Spatial Behavior | 1 | 2006 | 9 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2006 | 41 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2007 | 133 | 0.020 |
Why?
|
| Patient Transfer | 1 | 2005 | 23 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2005 | 39 | 0.020 |
Why?
|
| Psychotic Disorders | 1 | 2005 | 44 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2005 | 65 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2006 | 122 | 0.020 |
Why?
|
| gamma-Tocopherol | 1 | 2005 | 9 | 0.020 |
Why?
|
| alpha-Tocopherol | 1 | 2005 | 13 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 520 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2004 | 78 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 321 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 726 | 0.010 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2003 | 10 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2003 | 12 | 0.010 |
Why?
|
| Docosahexaenoic Acids | 1 | 2003 | 12 | 0.010 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2003 | 22 | 0.010 |
Why?
|
| Population | 1 | 2002 | 5 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2002 | 31 | 0.010 |
Why?
|
| Occupations | 1 | 2002 | 18 | 0.010 |
Why?
|
| beta Carotene | 1 | 2002 | 13 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2002 | 43 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 2002 | 41 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2002 | 107 | 0.010 |
Why?
|